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ABSTRACT (max 200 WORDS) 
Purpose of review: To summarize recent findings on conditioned pain modulation (CPM) in humans 
with a focus on methodology, factors modulating CPM, and the potential for CPM as a clinical marker 
for pain progression. 
Recent findings: CPM can be evoked by combining different stimulus modalities with good reliability, 
optimism and pain catastrophizing might influence pain inhibition, and sequential CPM-effects are 
stable over time with limited carry-over effects. Further, studies suggests that the CPM-effect can be 
improved by gabapentinoids, transcranial direct current stimulation to cortical structures and exercise 
and that long-term opioid use might impair CPM in patients with chronic pain. Clinically, increasing 
evidence suggests that preoperative impaired CPM may predict more severe chronic postoperative 
pain and the effect of pain duration on CPM impairment has been challenged by recent studies.  
Summary: The CPM methodology has been optimized and studies are revealing factors, which can 
modulated the descending pain inhibitory pathways. Understanding these mechanisms will improve 
the utility of CPM in a clinical setting and potentially lead to improvements in the treatment of 
chronic pain patients.   
INTRODUCTION  
The endogenous pain inhibitory system has received increasing attention over the last decade, as its 
function has been purported to explain discrepancies between tissue injury severity and degree of 
pain. In humans, the potency of this pain inhibitory system is primarily assessed by investigating the 
modulatory effect of a tonic painful conditioning stimulus on a painful test stimulus. This ‘pain-
inhibits-pain’ phenomenon was first described by Le Bars et al., in 1979(1), describing that noxious 
stimulus-elicited activity in convergent wide-dynamic-range neurons in the spinal dorsal horn could 
be blocked by another tonic noxious stimuli, and termed this effect, “diffuse noxious inhibitory 
control” (DNIC)(2). In 2010, an expert panel recommended to use DNIC when referring to pre-clinical 
studies and conditioned pain modulation (CPM) when referring to human studies using 
psychophysical protocols assessing the degree of ‘pain-inhibits-pain’(3), but both terms refer to the 
same presumed underlying descending inhibitory mechanisms. Pre-clinical trials have established that 
DNIC manifests as the inhibition of wide-dynamic-range neuronal activity by descending adrenergic 
pathways from the sub-reticularis dorsalis via the locus coeruleus(4). CPM is the human surrogate 
model for the estimate of this inhibitory effect, in reality giving the net effect of facilitatory and 
inhibitory systems(5). In most healthy subjects application of the conditioning stimulus will result in 
decreased pain sensitivity. Increasing evidence suggests that patients with severe and prolonged 
chronic pain do not demonstrate this decrease in pain sensitivity when a conditioning stimulus is 
applied(6) (see figure 1), suggesting that pain inhibitory mechanisms are impaired. 
The aim of this narrative review is to summarize the recent CPM literature with a focus on CPM 
methodology, modulation of CPM, and the potential for CPM as a clinical marker for pain progression. 
Contemporary findings were defined as studies published within the last years, which also partly drew 
selection of topics for this review.  
 
ADVANCEMENTS OF CPM METHODOLOGY  
The CPM recommendations from 2015(7) highlighted a lack consensus regarding CPM assessments 
and the need for comparison between protocols. In 2016, a systematic review(8) concluded that the 
degree of CPM reliability is dependent on stimulation parameters, highlighting the ongoing need for 
improvement of CPM methodology and the current section highlights recent advancements of CPM 
methodology. 
  
Multimodal assessment of CPM  
Recently, Imai et al.(9) assessed five different test stimuli (heat pain, electrical pain, single-point 
pressure pain thresholds, and cuff-induced pain detection and tolerance thresholds) with two 
different conditioning stimuli (the cold pressor test and tonic cuff pressure) in healthy subjects and 
found that most combinations could evoke a CPM response. In general, pressure-induced test and 
conditioning stimuli provoked CPM with good reliability (interclass correlations coefficients of approx. 
0.50)(9). This study adds to the knowledge that CPM can be evoked using e.g. both thermal and 
pressure-based test stimuli, which is in line with the current recommendations suggest using multi-
modal assessment of CPM(7). 
  
Neurophysiological methods to assess CPM 
Advances in the resolution of functional magnetic resonance imaging (fMRI) and source localization of 
electroencephalography (EEG) have allowed these techniques to be used to assess the functional 
connectivity of brain regions thought to be involved in descending pain inhibitory pathways. A study  
has identified that aberrant functional connectivity between the periaqueductal gray (PAG) and 
brainstem is associated with impaired CPM responses, while high resting connectivity between the 
cortex and the PAG was associated with enhanced CPM(10). Similarly, differences in regional brain 
morphology (e.g. in the orbitofrontal cortex) have also been associated to poor CPM efficiency(11). 
Such work helps to validate mechanisms assumed to underlie descending inhibition, but also 
highlights the complexity of the CPM-response in humans. Studies assessing both psychophysical CPM 
paradigms in combination with these neurophysiological measures are therefore strongly 
encouraged. 
 
Influence of pain catastrophizing and optimism on CPM 
Studies have demonstrated that higher levels of optimism is associated with e.g. placebo analgesic 
response, less temporal summation(12), greater CPM(13), and lower pain ratings to a cold pressor 
task(14). Two recent studies investigated the influence of optimism on CPM(15,16). Traxler et al.(15) 
manipulated optimism by using the so‐called “best possible self” method, which have been shown to 
increase optimism temporarily(17), but this had no effect on heat or cold pain sensitivity or CPM, 
which is in contrast to previous findings. Traxler et al.(15) did find that higher pain catastrophizing was 
associated with less CPM effect. In contrast, Hinkle and Quiton(16) reported that high optimism 
predicted less CPM effect, and together with the Traxler et al.(15) these data challenge the 
association between the level of optimism and CPM. High pain catastrophizing has previously been 
found associated with pain severity and poor pain alleviation to treatments(18) and therefore 
investigating the interplay between pain catastrophizing, optimism and CPM in both experimental and 
clinical settings is encouraged.  
 
Duration of the conditioning effect on pain sensitivity 
Until recently little was known about the temporal dynamics of CPM although it has been suspected 
to have carry-over effects on subsequent experimental tests, as ongoing reduced pain sensitivity has 
been documented to last for a few minutes(19). However, Hoegh et al.(20) investigated this by 
applying four sequential CPM paradigms in five minute blocks using the deep-somatic pressure-cuffs 
and found that the CPM effect remained stable over time. This could indicate that deep somatic 
provoked CPM measures are less influenced by carry-over effects than previously thought.  
  
Age and sex influences on CPM 
CPM has been suggested to decline with age, as middle-aged to older participants generally show 
reduced inhibitory responses compared to younger participants(21,22). Females are over-represented 
in chronic pain populations and sex differences in pain threshold and tolerance measures have 
consistently been found for pressure pain and cutaneous electrical stimulation(23). Further, a 
systematic review from 2010 concluded a more efficient CPM to be found in males compared with 
females(24). To further investigate this, Skovbjerg et al.,(25) conducted a study on 2,199 randomly 
selected adults from the general population in Denmark, demonstrating that CPM was less efficient in 
females compared with males, but that CPM was unaffected by age. This study further increases the 
awareness that sex influences assessment of pain, and therefore should considered in future studies. 
  
NEUROPLASTIC CHANGES OF PAIN INHIBITORY PATHWAYS 
Maladaptive neuroplastic changes can occur from prolonged peripheral drive to the central nervous 
system(6,26). Impaired CPM is well documented in severe chronic pain patients compared with 
healthy subjects(6) and recent studies have therefore started to investigate how interventions may 
influence CPM in a maladaptive or advantageous manner. 
 
Advantageous neuroplastic changes in pain inhibitory pathways 
Pregabalin 
Pregabalin is a gabapentinoid that has previously been used to modulate central sensitization in e.g. 
chronic pancreatitis(27). Wodehouse et al.,(28) followed 25 patients with fibromyalgia to whom 
pregabalin was administrated (75 mg twice daily) for 12 weeks resulting in reduced clinical pain and 
improved CPM. This study adds to our current knowledge that pregabalin could improve pain 
inhibitory processes, but it is noteworthy that more than 40% of patients discontinued the pregabalin 
treatment, hence these results need replication in larger studies to document the same effect. 
Nonetheless, it is not clear if the CPM improvement was directly caused by the action of pregabalin or 
because other pain mechanisms were reversed, causing reduced clinical pain and thus increasing 
efficacy of CPM. 
   
Transcranial direct current stimulation 
Recent studies have indicated that transcranial direct current stimulation (tDCS) and other 
transcranial stimulation methods, such as repetitive transcranial magnetic stimulation (rTMS), can 
modulate musculoskeletal pain development in experimental settings(29,30) and yield pain relief in 
patients with fibromyalgia(31,32). As patients with knee osteoarthritis often display impaired CPM 
compared to healthy subjects(33), a recent study by Ahn et al.,(34) assessed the modulatory effect of 
tDCS on CPM in patients with osteoarthritis. This study found that tDCS on the primary motor cortex 
could improve CPM, and reduce pain sensitivity to pressure, mechanical punctuate pain and heat, 
arguing that pain relief occurred through advantageous neuroplastic changes. It is of note, that this 
study was controlled by a sham-group but that the sample size was low and while these data are of 
high interest, these findings need to be replicated in large clinical cohorts. Interestingly, the 
transcranial stimulation techniques also allow targeting specific structures or brain networks that may 
be a particular interesting approach to study CPM mechanisms in future studies.  
 
Effect of exercise programs on CPM 
Long-term exercise programs provides pain relief for multiple patient groups with persistent pain(35). 
The mechanisms thought to underlie the pain relieving effects of exercise includes activation of the 
descending pain inhibitory pathways(36), decreased pro-inflammatory cytokine response(37), and a 
reduction in psychological distress(38). Beyond this, the mechanisms are largely unknown(36). In a 
recent study, Heredia-Rizo et al.,(39) evaluated females with neck and shoulder pain before and after 
a 5-week upper trapezius eccentric training program.  An average of approximately 65% pain relief 
was reported and this was associated with an improvement in CPM. Future studies are encouraged to 
investigate if long-term exercise can promote improvements in pain inhibitory pathways and to 
investigate if the CPM improvements are independent of clinical pain reduction. 
 
Maladative neuroplastic changes of pain inhibitory pathways 
Opioids 
De Resende et al.,(40) studied DNIC effects in rats by administrating naloxone (an opioid antagonist 
targeting the µ-receptors) and found this to prevent DNIC responses. Martel et al., (41) studied CPM 
response in 190 chronic neck and low back pain patients who were either current opioid-users (64 % 
of the sample) or non-users and found that CPM was impaired in opioid-users compared with non-
users. Of note, difference in clinical pain intensities were reported in the Martel et al study(41), which 
could be the driving factor for the CPM impairment but despite this, these findings are consistent with 
previous studies in patients with chronic pain(42,43). Interestingly, experimental studies have suggest 
that acute use of opioids might improve the CPM response(44,45). Overall, this series of studies 
suggest that the pain inhibitory pathways may be positively impacted by acute opioid use, but that 
chronic use might cause impairment, which is of high relevance due to the opioid misuse epidemic 
occurring worldwide and further research within this field is encouraged.  
 
PAIN PROGRESSION AND PAIN INHIBITORY PATHWAYS  
In 2008, Yarnitsky and colleagues(46) demonstrated that impaired preoperative CPM was associated 
with more severe chronic postoperative pain in patients undergoing thoracotomy. Wilder-Smith et 
al.,(47) followed with a study in patients undergoing abdominal surgery demonstrating similar results. 
Further, Yarnitsky et al.,(48) demonstrated that the degree of CPM impairment was associated with 
the drug efficacy of duloxetine (a serotonin-noradrenalin reuptake inhibitor). Together, these studies 
have formed the foundation of CPM as a measure for personalized pain medicine.  
 
Prediction of chronic postoperative pain 
Vaegter et al.,(49) found that impaired CPM prior to total knee arthroplasty was associated with less 
pain relief six months after surgery, which adds to the growing evidence that patients with severely 
preoperatively senstized pain mechanisms are in greater risk of chronic postoperative pain(46,47,50). 
In addition, Vaegter et al.,(49) reported that greater pain relief was associated with normalization of 
CPM, indicating that high pain intensity, potentially as a result of increased nociceptive activity, could 
be maintaining the impairment in pain inhibitory pathways. This finding is also supported by older 
studies in patients undergoing total hip(51) and knee(52) arthroplasty. More recent studies applying 
similar methodology in larger clinical cohorts have been unable to demonstrate an association 
between preoperative impaired CPM and chronic postoperative pain after total hip(53) and knee 
arthroplasty(50,54,55) and therefore the conclusion regarding CPM as a predictor for total  joint 
arthroplasty is still debated.  
 
Transition from acute to chronic pain and back  
A recent preclinical monoiodoacetate model of osteoarthritis highlighted that DNIC is functional in 
early stages of osteoarthritis and abolished in the later stages(56) suggesting that prolonged disease 
severity is associated with impairment in pain inhibitory pathways.   
Studies on patients with musculoskeletal pain have found that intense pain for longer duration can 
impair CPM(26,57,58) but the causality between pain intensity, pain duration and impaired CPM is 
unclear. Experimental pain models have been utilized to understand the transition from acute to 
chronic pain, but these are limited to: 1) intense pain for a short duration (i.e. the hypertonic 
saline(59) or acid(60) models), or 2) muscle soreness for a longer duration but without spontaneous 
pain (i.e. delayed on of muscle soreness (DOMS)(61) and nerve growth factor (NGF)(62)). In these 
cases, intense acute pain (akin to a second conditioning stimulus) has been demonstrated to abolish 
the usual inhibitory response(63), but experimental back pain induced by eccentric exercise was 
unable to produce the same impairing effect on CPM(61).  
In a recent study, Holden et al.,(64) aimed to investigate pain sensitivity of central pain 
mechanisms in young females with current and past long-standing patellofemoral pain compared with 
healthy subjects. Interestingly, the females with current and past history of patellofemoral pain 
displayed facilitated temporal summation of pain compared to healthy subjects but no difference 
were found for CPM. Teles et al.,(65) studied adolescents with idiopathic scoliosis and chronic low 
back pain and found a variation in the CPM results, so that approx. 50% displayed efficient CPM, 
approx. 20% displayed sub-optimal CPM and approx. 30% displayed impaired CPM. Further, Teles et 
al., (65) did not find an association between CPM impairment and pain duration, which is similar to 
Holden et al.,(64). Since these studies were conducted in young females, this could indicate that CPM 
is not disrupted in the early stages of pain chronification, but more studies are needed to determine 
this. 
Palsson et al.,(66) investigated subjects who recovered from a previous ankle injury and found 
these individuals to have enhanced CPM responses compared to subjects without prior trauma, which 
could indicate that the pain inhibitory systems are highly active when recovering from an injury. This 
is in line with Holden et al.,(64), demonstrating that individuals who had recovered from adolescent 
patellofemoral pain showed enhanced CPM compared to those with ongoing pain however it is 
unclear if the CPM alterations are driven by pain intensities. Currently, there is limited information 
regarding CPM in the recovery phase or following persistent pain resolution, so studies similar to 
these are encouraged.  
In summary, these new studies(64–66) challenge the hypothesis that longer pain duration is 
associated with less efficient CPM. Of note, previous studies demonstrating an association between 
pain duration and less efficient CPM have been conducted in patient populations with pain durations 
for decades e.g. severe osteoarthritis pain(26,58) and these new studies are all conducted in patient 
populations with pain durations of a few months or years.   
 
CONCLUSION  
This review highlighted that there is large growth in both experimental and clinical CPM-related 
research (summary found in figure 2). Recent studies show that CPM can be assessed in a multimodal 
manner, that there is limited carry-over effects of CPM, and that the potency of CPM is lower in 
females compared with males. Further, pregabalin seems to improve CPM in fibromyalgia, tDCS may 
improve CPM in osteoarthritis, endurance training may be more effective at enhancing CPM 
compared to strength training. Finally, a few studies have investigated CPM in patients with short 
duration (months to years) chronic pain and found mixed results regarding impairment of the pain 
inhibitory pathways. Important questions to be studied includes the specific dynamic characteristics 
of CPM, such as how much and for how long is ongoing pain needed to modulate CPM, and 
importantly is ongoing pain in patients needed to demonstrate reduced efficacy of the descending 
pain control system.   
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SUMMARY – BULLET POINTS 
1. Conditioned pain modulation (CPM) is a human assessment of descending inhibitory 
mechanisms, which has shown good test-retest reliability without carry-over effects but might 
be influenced by psychological factors. 
2. Advantageous neuroplasticity can occur due to acute pharmacological modulation, non-
invasive brain stimulation and exercise programs. 
3. Maladaptive neuroplasticity due to prolonged opioid use, ongoing pain or increasing age. 
4. CPM is improved when a painful condition is resolved.  
5. Impaired CPM may predict pharmaceutical efficacy and chronic postoperative pain.  
  
Figure legends 
Figure 1: Assessment of conditioned pain modulation (CPM) requires a test stimulus (e.g. pressure 
pain thresholds at the knee) and a painful conditioned test stimulus (e.g. tonic painful pressure). In 
healthy subjects, the conditioning stimulus will result in reduced pain sensitivity (increased 
thresholds), indicating an activation of pain pathways under descending noxious control, which are 
impaired in many chronic pain disorders. Modified based on data from Arendt-Nielsen et al.(26) (24 
healthy controls, 24 knee osteoarthritis (KOA) pain patients). * indicate significant difference between 
the conditioned on unconditioned test stimuli. 
 
Figure 2: Recent findings on conditioned pain modulation (CPM) in humans with a focus on (A) 
methodology, (B) factors modulating CPM, and (C) the clinical use of CPM. (A) A conditioned test 
stimulus (e.g. pain threshold) will change (e.g. increased pain threshold) compared with an 
unconditioned test stimulus in healthy subjects (illustrated in blue), which does not occur in chronic 
pain patients (illustrated in red), the assessment show good reliability with no carry-over effect but 
might be influenced by pain catastrophizing or optimism. (B) Acute pharmacological interventions 
(e.g. Pregabalin), non-invasive brain stimulation (e.g. transcranial direct current stimulation and 
repetitive transcranial magnetic stimulation), and long-term exercise might enhance descending pain 
control whereas ongoing pain, prolonged use of opioids, and increasing age might impair descending 
pain control. (C) CPM is improved when pain is resolved and impaired CPM might be utilized to 
predict poor pain relief to surgery and certain pharmacological interventions. 
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